Document is current
Any future updates will be listed below
-
Authors
Monje, Paula V. https://orcid.org/0000-0002-5274-9238
Bacallao, Ketty
Aparicio, Gabriela I.
Lalwani, Anil
-
Funding
Funding for this research was provided by:
indiana state department of health (33997, 43547)
buoniconti fund to cure paralysis
- License Information
-
More Information
Article History
Received: 17 June 2021
Accepted: 16 October 2021
First Online: 12 November 2021
Declarations
:
: Not applicable.
: Not applicable.
: A portion of this work was described in Dietrich WD, Investigational New Drug Application for the use of autologous human Schwann Cells (IND # 14856), approved by the Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Cellular, Tissue and Gene Therapy (US) in 2012. P.V.M., K.B. and A.L. contributed work presented in IND 14856 while affiliated to The Miami Project to Cure Paralysis working under the leadership of Dr. Dalton Dietrich. P.V.M. is the founder of GliaBio LLC, a consulting company that focuses on basic and translational glial cell research. The authors of this article declare that the research described here was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
